ID   ILCLs14
AC   CVCL_C1EQ
SY   ILCL s14
DR   Wikidata; Q114311723
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/ILCLs14_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1ER ! ILCLs21
OI   CVCL_C1ES ! ILCLs23
OI   CVCL_C1ET ! ILCLs31
OI   CVCL_C1EU ! Ff-CLs14
OI   CVCL_C1EV ! Ff-CLs21
OI   CVCL_C1EW ! Ff-CLs23
OI   CVCL_C1EX ! Ff-CLs31
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
RX   PubMed=31497180; DOI=10.1186/s41232-019-0106-0; PMCID=PMC6717959;
RA   Umekage M., Sato Y., Takasu N.;
RT   "Overview: an iPS cell stock at CiRA.";
RL   Inflamm. Regen. 39:17.1-17.5(2019).
//
RX   PubMed=36395757; DOI=10.1016/j.medj.2022.10.003;
RA   Yoshida S., Kato T.M., Sato Y., Umekage M., Ichisaka T., Tsukahara M.,
RA   Takasu N., Yamanaka S.;
RT   "A clinical-grade HLA haplobank of human induced pluripotent stem
RT   cells matching approximately 40% of the Japanese population.";
RL   Med 4:51-66.e10(2023).
//